Evidence map›Paper›PMID 34327218›Full record

ArticleCase reports in nephrology and dialysis

Patiromer in a Patient with Severe Hyperkalemia on Incremental Hemodialysis with 1 Session per Week: A Case Report and Literature Review.

José C De La Flor, Javier Deira, Alexander Marschall, Francisco Valga, Tania Linares, Tania Monzon, Cristina Albarracín, Elisa Ruiz

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in nephrology and dialysis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

José C De La FlorDepartment of Nephrology, Central Defense Gomez Ulla Hospital, Madrid, Spain.
Javier DeiraDepartment of Nephrology, San Pedro de Alcantara Hospital, Caceres, Spain.
Alexander MarschallDepartment of Cardiology, Central Defense Gomez Ulla Hospital, Madrid, Spain.
Francisco ValgaDepartment of Nephrology, Doctor Negrín University Hospital, Las Palmas de Gran Canarias, Las Palmas, Spain.
Tania LinaresDepartment of Nephrology, Central Defense Gomez Ulla Hospital, Madrid, Spain.
Tania MonzonDepartment of Hemodialysis, Avericum S.L., Las Palmas de Gran Canarias, Las Palmas, Spain.
Cristina AlbarracínDepartment of Nephrology, Central Defense Gomez Ulla Hospital, Madrid, Spain.
Elisa RuizDepartment of Nephrology, Central Defense Gomez Ulla Hospital, Madrid, Spain.
Hospital Central de la Defensa Gómez Ulla · ESHospital San Pedro de Alcántara · ESHospital Universitario de Gran Canaria Doctor Negrín · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperkalemia is common in patients with ESRD, undergoing hemodialysis (HD), and is associated with an increase in hospitalization and mortality. Residual kidney function in long-term dialysis patients is associated with lower morbidity and mortality in HD patients. Although the 2015 National Kidney Foundation-Kidney Disease Outcomes Quality Initiate (NKD-KDOQI) guidelines allow the reduction in the weekly HD dose for patients with a residual kidney urea clearance (Kur) >3 mL/min/1.73 m

Indexed as

HyperkalemiaIncremental hemodialysisPatiromer sorbitex calcium

Identifiers

PMID34327218
PMCPMC8299388
OpenAlexW3173317652

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.